AAAAAA

   
Results: 1-20 |
Results: 20
Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease
Authors: Klings, ES Farber, HW
Citation: Es. Klings et Hw. Farber, Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease, RESPIR RES, 2(5), 2001, pp. 280-285
Increased F-2 isoprostanes in the acute chest syndrome of sickle cell disease as a marker of oxidative stress
Authors: Klings, ES Christman, BW McClung, J Stucchi, AF McMahon, L Brauer, M Farber, HW
Citation: Es. Klings et al., Increased F-2 isoprostanes in the acute chest syndrome of sickle cell disease as a marker of oxidative stress, AM J R CRIT, 164(7), 2001, pp. 1248-1252
Gas 6 promotes Axl-mediated survival in pulmonary endothelial cells
Authors: Healy, AM Schwartz, JJ Zhu, XH Herrick, BE Varnum, B Farber, HW
Citation: Am. Healy et al., Gas 6 promotes Axl-mediated survival in pulmonary endothelial cells, AM J P-LUNG, 280(6), 2001, pp. L1273-L1281
Induction of endothelial cell cytoplasmic lipid bodies during hypoxia
Authors: Scarfo, LM Weller, PF Farber, HW
Citation: Lm. Scarfo et al., Induction of endothelial cell cytoplasmic lipid bodies during hypoxia, AM J P-HEAR, 280(1), 2001, pp. H294-H301
Lipopolysaccharide binding protein potentiates airway reactivity in a murine model of allergic asthma
Authors: Strohmeier, GR Walsh, JH Klings, ES Farber, HW Cruikshank, WW Center, DM Fenton, MJ
Citation: Gr. Strohmeier et al., Lipopolysaccharide binding protein potentiates airway reactivity in a murine model of allergic asthma, J IMMUNOL, 166(3), 2001, pp. 2063-2070
Current management of primary pulmonary hypertension
Authors: Klings, ES Farber, HW
Citation: Es. Klings et Hw. Farber, Current management of primary pulmonary hypertension, DRUGS, 61(13), 2001, pp. 1945-1956
Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension
Authors: Aguilar, RV Farber, HW
Citation: Rv. Aguilar et Hw. Farber, Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension, AM J R CRIT, 162(5), 2000, pp. 1846-1850
VEGF is deposited in the subepithelial matrix at the leading edge of branching airways and stimulates neovascularization in the murine embryonic lung
Authors: Healy, AM Morgenthau, L Zhu, XH Farber, HW Cardoso, WV
Citation: Am. Healy et al., VEGF is deposited in the subepithelial matrix at the leading edge of branching airways and stimulates neovascularization in the murine embryonic lung, DEV DYNAM, 219(3), 2000, pp. 341-352
Induction of heme oxygenase-1 by hypoxia and free radicals in human dermalfibroblasts
Authors: Panchenko, MV Farber, HW Korn, JH
Citation: Mv. Panchenko et al., Induction of heme oxygenase-1 by hypoxia and free radicals in human dermalfibroblasts, AM J P-CELL, 278(1), 2000, pp. C92-C101
Propylene glycol toxicity in a patient receiving intravenous diazepam
Authors: Wilson, KC Reardon, C Farber, HW
Citation: Kc. Wilson et al., Propylene glycol toxicity in a patient receiving intravenous diazepam, N ENG J MED, 343(11), 2000, pp. 815-815
Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia
Authors: Eberhardt, RT Forgione, MA Cap, A Leopold, JA Rudd, MA Trolliet, M Heydrick, S Stark, R Klings, ES Moldovan, NI Yaghoubi, M Goldschmidt-Clermont, PJ Farber, HW Cohen, R Loscalzo, J
Citation: Rt. Eberhardt et al., Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia, J CLIN INV, 106(4), 2000, pp. 483-491
IV epoprostenol for systemic sclerosis
Authors: Klings, ES Farber, HW
Citation: Es. Klings et Hw. Farber, IV epoprostenol for systemic sclerosis, CHEST, 118(3), 2000, pp. 881-882
Epoprostenol for pulmonary hypertension in scleroderma
Authors: Klings, ES Farber, HW
Citation: Es. Klings et Hw. Farber, Epoprostenol for pulmonary hypertension in scleroderma, ANN INT MED, 133(2), 2000, pp. 158-158
Endothelial cell nitric oxide production in acute chest syndrome
Authors: Hammerman, SI Klings, ES Hendra, KP Upchurch, GR Rishikof, DC Loscalzo, J Farber, HW
Citation: Si. Hammerman et al., Endothelial cell nitric oxide production in acute chest syndrome, AM J P-HEAR, 277(4), 1999, pp. H1579-H1592
Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma
Authors: Farber, HW Graven, KK Kokolski, G Korn, JH
Citation: Hw. Farber et al., Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma, J RHEUMATOL, 26(5), 1999, pp. 1195-1196
Identification of an oxygen responsive enhancer element in the glyceraldehyde-3-phosphate dehydrogenase gene
Authors: Graven, KK Yu, Q Pan, D Roncarati, JS Farber, HW
Citation: Kk. Graven et al., Identification of an oxygen responsive enhancer element in the glyceraldehyde-3-phosphate dehydrogenase gene, BBA-GENE ST, 1447(2-3), 1999, pp. 208-218
Prothrombotic mechanisms in primary pulmonary hypertension
Authors: Farber, HW Loscalzo, J
Citation: Hw. Farber et J. Loscalzo, Prothrombotic mechanisms in primary pulmonary hypertension, J LA CL MED, 134(6), 1999, pp. 561-566
Systemic sclerosis-associated pulmonary hypertension - Short- and long-term effects of epoprostenol (prostacyclin)
Authors: Klings, ES Hill, NS Ieong, MH Simms, RW Korn, JH Farber, HW
Citation: Es. Klings et al., Systemic sclerosis-associated pulmonary hypertension - Short- and long-term effects of epoprostenol (prostacyclin), ARTH RHEUM, 42(12), 1999, pp. 2638-2645
Successful treatment of chylous ascites secondary to Mycobacterium avium complex in a patient with the acquired immune deficiency syndrome
Authors: Keaveny, AP Karasik, MS Farber, HW
Citation: Ap. Keaveny et al., Successful treatment of chylous ascites secondary to Mycobacterium avium complex in a patient with the acquired immune deficiency syndrome, AM J GASTRO, 94(6), 1999, pp. 1689-1690
Endothelial Cell hypoxic stress proteins
Authors: Graven, KK Farber, HW
Citation: Kk. Graven et Hw. Farber, Endothelial Cell hypoxic stress proteins, J LA CL MED, 132(6), 1998, pp. 456-463
Risultati: 1-20 |